Press Release: Sebela Pharmaceuticals : Sebela Women's Health Announces Positive Phase 3 Data for its Investigational, Next-Generation, Hormone-Free, Low-Dose Copper Intrauterine Device (IUD)
If approved by the U.S. Food and Drug Administration, this newly designed, low-dose copper IUD could be the first...
Read full article »
Sebela Pharmaceuticals develops and markets prescription products for gastroenterology, dermatology and women’s health.
Read more